المؤلفون: de Jonge, P. K. J. D., van Hauten, P. M. M.^{Aff1, Aff2}, Janssen, L. D., de Goede, A. L., Berrien-Elliott, M. M., van der Meer, J. M. R., Mousset, C. M., Roeven, M. W. H., Foster, M., Blijlevens, N., Hobo, W., Fehniger, T. A., Jansen, J. H., Schaap, N. P. M., Dolstra, H.^{Aff1, IDs00262023034926_cor15}

المصدر: Cancer Immunology, Immunotherapy. :1-13

المؤلفون: de Jonge, P. K. J. D., van Hauten, P. M. M., Janssen, L. D., de Goede, A. L., Berrien-Elliott, M. M., van der Meer, J. M. R., Mousset, C. M., Roeven, M. W. H., Foster, M., Blijlevens, N., Hobo, W., Fehniger, T. A., Jansen, J. H., Schaap, N. P. M., Dolstra, H.

المصدر: Cancer Immunology, Immunotherapy; Oct2023, Vol. 72 Issue 10, p3323-3335, 13p

مصطلحات موضوعية: KILLER cells, ACUTE myeloid leukemia, CURRENT good manufacturing practices, ARYL hydrocarbon receptors, HEMATOPOIETIC stem cells

المؤلفون: Muth, J., Leedom, T., Magee, K., Muz, B., Vadakekulathu, J., Petit, V., Bhatnagar, N., Primo, D., Pennacchi, P. Comune, Berrien-Elliott, M., Fehniger, T.A., Davidson-Moncada, J., Rutella, S.

المصدر: In Annals of Oncology October 2023 34 Supplement 2:S1173-S1173

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: Rutella, S., Muth, J., Vadakekulathu, J., Mathyer, M.E., Tumala, B.R., Foster, M., Baughman, J., Comune Pennacchi, P., Tolstikov, V., Carter, A., Primo, D., Gorrochategui, J., Magee, K., Shah, P., Kiebish, M., Ballesteros, J., Cooper, M.L., Berrien-Elliott, M., Fehniger, T.A., Davidson-Moncada, J.K.

المصدر: In Annals of Oncology September 2022 33 Supplement 7:S549-S550

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

المؤلفون: O'Neal J; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO., Cooper ML; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Ritchey JK; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Gladney S; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Niswonger J; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., González LS; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Street E; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Haas GJ; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Carter A; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Amayta PN; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO., Gao F; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, Saint Louis, MO., Lee BH; NeoImmuneTech, Inc, Rockville, MD., Choi D; NeoImmuneTech, Inc, Rockville, MD., Berrien-Elliott M; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO., Zhou A; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO., Fehniger TA; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO., Rettig MP; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO., DiPersio JF; Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO.; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO.

المصدر: Blood advances [Blood Adv] 2023 Oct 24; Vol. 7 (20), pp. 6009-6022.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Multiple Myeloma*/genetics , Receptors, Chimeric Antigen*/metabolism , Graft vs Host Disease*/etiology , Graft vs Host Disease*/prevention & control, Humans ; Animals ; Mice ; Interleukin-7 ; B-Cell Maturation Antigen ; Receptors, Antigen, T-Cell/genetics